A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Clinical trial NCT01231516 · COMPLETED
Trial details
- NCT number
- NCT01231516
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-26
- Primary completion
- 2013-02-04
- Enrollment
- 724
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.